GLP-1 Medications Fuel Growth in Medical Aesthetics, with Weight Loss Accounting for 11% of Non-Surgical Spending in 2024 GLP-1 medications drove 13% of non-surgical aesthetic spend in 2024, reshaping the $19.2B industry as medspas see rising revenue and younger patients.

Guidepoint Qsight and Skytale Group Report 9% Surge in Medical Aesthetic Non-Surgical Revenues in First Half of 2024 Medical aesthetics non-surgical revenues rose 9% in H1 2024, driven by semaglutides, neurotoxins, and a growing consumer base, per Guidepoint & Skytale.

Guidepoint Qsight Launches Qsight Prospector: The Medical Aesthetics Industry's First Data-Driven Sales Intelligence Platform Guidepoint Qsight launches Qsight Prospector, the first data-driven sales platform for the medical aesthetics industry.

Guidepoint Qsight Takes Aesthetics Market Intelligence Global, Launching Expanded Tracker to Ten Key Markets Guidepoint Qsight expands Aesthetics Practitioner Tracker to 10 global markets, revolutionizing industry intelligence for strategic decision-making.